Aim: To investigate the efficacy of lifestyle adjustment strategies as a preventive measure
and/or treatment of obesity-related non-alcoholic fatty liver disease in adults. Method: A …

Non-alcoholic fatty liver disease (NAFLD), the most common cause of liver disease, affects
approximately 75 to 100 million Americans. Patients with concurrent NAFLD and type 2 …

The prevalence of hepatitis C in pregnancy is as high as 3.6% in large cohorts. The
prevalence of hepatitis C acquired by vertical transmission is 0.2% to 0.4% in the United …

This population-based study investigated gender differences in the use of coping strategies
and their relationship to anxiety symptoms during the initial COVID-19 lockdown period in …

As a chronic disease encompassing a wide spectrum of liver-related histologic damage,
nonalcoholic fatty liver disease (NAFLD) is becoming a global epidemic with significant …

The major risk factor for developing hepatocellular carcinoma (HCC) is chronic liver disease,
with hepatitis C virus (HCV) and alcohol-related liver disease (ARLD) predominating …

Background In 2015, prescription opioids and heroin overdoses resulted in more than
30,000 fatalities in the United States (US). 1 The preventable deaths in these young and …

Background: With all-cause mortality increasing in patients undergoing PCIs, outcomes for
GIB associated with PCI may be adversely impacted. Study: Using the National Inpatient …

Tu1268: LONGITUDINAL ASSESSMENT OF SEROLOGICAL RESPONSE AFTER THREE
DOSES OF SARS-COV-2 MRNA VACCINE IN LIVER TRANSPLANT RECIPIENTS - PMC Back …

Background: Hepatocellular carcinoma (HCC) is the second most fatal cancer worldwide,
but there is a lack of therapies that target definable molecular changes that drive tumor …